Pfizer Beat Sanofi To Isolated DNA Patent, Fed. Circ. Says

Law360, New York (November 5, 2013, 4:05 PM EST) -- The Federal Circuit ruled Tuesday that Pfizer Inc. should be awarded the patent for a DNA sequence that Pfizer and rival pharmaceutical manufacturer Sanofi-Aventis SA had simultaneously researched and both claimed the rights to, ruling that Pfizer beat its competitor to isolating the disputed segment.

The panel affirmed a finding by the Board of Patent Appeals and Interferences that Pfizer scientists developed the DNA sequence before the effective filing date of Sanofi's patent, rejecting Sanofi's argument that it knew the complete and correct sequence before Pfizer....
To view the full article, register now.